Tag: Global Blood Therapeutics

By Posted on Posted in Fundamental Valuation Report

Fundamental Valuation Report PTC Therapeutics(PTCT:NAS) Healthcare:Biotechnology This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$38.29 (USD) 05/12/2021 Weighted Valuation$38.22 (USD) Overall RatingFairly valued to slightly Overvalued by 0.2% Valuation Models Multiples: $33.22 …

PTC Therapeutics (PTCT:NAS) Fundamental Valuation Report Read more »

Read More

By Posted on Posted in Fundamental Valuation Report

Fundamental Valuation Report Intra-Cellular Therapies(ITCI:NAS) Healthcare:Biotechnology This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$34.43 (USD) 04/30/2021 Weighted Valuation$26.38 (USD) Overall RatingOvervalued by 23.4% Valuation Models Comparables: $26.38 (USD) Valuation Methods …

Intra-Cellular Therapies (ITCI:NAS) Fundamental Valuation Report Read more »

Read More

By Posted on Posted in Fundamental Valuation Report

Fundamental Valuation Report Editas Medicine(EDIT:NAS) Healthcare:Biotechnology This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$40.99 (USD) 03/24/2021 Weighted Valuation$40.70 (USD) Overall RatingFairly valued to slightly Overvalued by 0.7% Valuation Models Adjusted …

Editas Medicine (EDIT:NAS) Fundamental Valuation Report Read more »

Read More